BASSIA SCOPARIA POLLEN: 30 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
30
Total FAERS Reports
0
Deaths Reported
1
Hospitalizations
30
As Primary/Secondary Suspect
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20160103 · Latest Report: 20230508
What Are the Most Common BASSIA SCOPARIA POLLEN Side Effects?
#1 Most Reported
Urticaria
11 reports (36.7%)
#2 Most Reported
Anaphylactic reaction
8 reports (26.7%)
#3 Most Reported
Cough
6 reports (20.0%)
All BASSIA SCOPARIA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Urticaria | 11 | 36.7% | 0 | 0 |
| Anaphylactic reaction | 8 | 26.7% | 0 | 0 |
| Cough | 6 | 20.0% | 0 | 1 |
| Hypersensitivity | 5 | 16.7% | 0 | 0 |
| Injection site reaction | 5 | 16.7% | 0 | 0 |
| Pruritus | 5 | 16.7% | 0 | 0 |
Who Reports BASSIA SCOPARIA POLLEN Side Effects? Age & Gender Data
Gender: 53.8% female, 46.2% male. Average age: 31.9 years. Most reports from: US. View detailed demographics →
Is BASSIA SCOPARIA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 5 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 2 | 0 | 1 |
| 2021 | 12 | 0 | 0 |
| 2022 | 4 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for BASSIA SCOPARIA POLLEN
Official prescribing information from the FDA-approved drug label.